We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01121640
First Posted: May 12, 2010
Last Update Posted: August 21, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
The Marsha Rivkin Center for Ovarian Cancer Research
Canary Foundation
Swedish Medical Center
City of Hope Medical Center
Cedars-Sinai Medical Center
Stanford University
Fox Chase Cancer Center
Information provided by (Responsible Party):
Fred Hutchinson Cancer Research Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2018
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)